HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
2276studies shown
Showing 865-876 of 2,276
Drug study icon
CompletedNCT00357006

A Definitive Estrogen Patch Study (ADEPT)

Official study title

Multisite Double-Blind Randomized Controlled Study of Estradiol Plus Antipsychotic Versus Placebo Plus Antipsychotic in the Treatment of Psychotic Symptoms in Women With Schizophrenia

This study has finished and is no longer accepting participants.

In Australia
Schizophrenia, BipolarityMedication studyAges 18–50
Countries
Australia
Sponsor
The Alfred
Other study type icon
CompletedACTRN12623000907640

A digital anxiety intervention for children with reading difficulties

Official study title

A randomised controlled trial of the efficacy of a digital anxiety intervention for children with reading difficulties and anxiety

This study has finished and is no longer accepting participants.

In Australia
AnxietyInterventional studyAges 7–12
Countries
Australia
Sponsor
University of New South Wales
Other study type icon
CompletedACTRN12621000766819

A digital solution to address the mental health and psychosocial impacts of the pandemic for children and their parents in the first 2000 days

Official study title

“Watch Me Grow- Electronic (WMG-E)” surveillance approach to identify and address child development, parental mental health, and psychosocial needs.

This study has finished and is no longer accepting participants.

In Australia
Mental healthInterventional studyAges 6 months–3 years
Countries
Australia
Sponsor
South Western Sydney Local Health District
Device study icon
CompletedNCT00168311

Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation in the Treatment of Negative Symptoms for schizophrenia

Official study title

A Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magentic Stimulation (rTMS) in the Treatment of Negative Symptoms in Schizophrenia and Related Disorders

This study has finished and is no longer accepting participants.

In Australia
SchizophreniaDevice studyAges 18–70
Countries
Australia
Sponsor
The Alfred
Drug study icon
CompletedACTRN12622000713796

Safety study of Single, Ascending, Subcutaneous Doses of FT-104 HCl in Depression

Official study title

A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single, Ascending, Subcutaneous Doses of FT-104 HCl In Healthy Volunteers Safety, Tolerability, and Pharmacokinetics of Subcutaneous FT-104 HCl (SAIL-101)

This study has finished and is no longer accepting participants.

In Australia
DepressionInterventional studyAges 18–65
Countries
Australia
Sponsor
Field Trip Psychedelics Inc
Other study type icon
CompletedACTRN12623001231639

A further examination of the short-term anxiolytic effects of an Echinacea extract (EP107) in adults experiencing increased anxiety

Official study title

A further examination of the short-term anxiolytic effects of an Echinacea extract (EP107) in adults experiencing increased anxiety: A randomised, double-blind, placebo-controlled trial

This study has finished and is no longer accepting participants.

In Australia
AnxietyInterventional studyAges 18–80
Countries
Australia
Sponsor
Clinical Research Australia

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.